Anthelmintics for people with neurocysticercosis
Author:
Affiliation:
1. Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK
2. Department of Primary Care and Mental Health; University of Liverpool; Liverpool UK
3. Institute of Neurology; Madras Medical College; Chennai India
Publisher
Wiley
Subject
Pharmacology (medical)
Reference64 articles.
1. Short course of albendazole therapy for neurocysticercosis: a prospective randomized trial comparing three days, eight days and the control group without albendazole;Alarcon;Revista Ecuatoriana de Neurologia,2001
2. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo controlled, double-blind trial;Baranwal;Pediatric Infectious Disease Journal,1998
3. Morphometry of single small enhancing computed tomographic lesions: outcome and effect of albendazole therapy;Baranwal;Journal of Tropical Pediatrics,2002
4. Seizure recurrence and single small enhancing computed tomographic lesions: prognostic factors on long-term follow-up;Baranwal;Journal of Child Neurology,2001
5. Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis;Carpio;Epilepsia,2019
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment Outcome in Patients with Disseminated Cysticercosis: A Systematic Review of Case Reports and Case Series;The American Journal of Tropical Medicine and Hygiene;2024-06-05
2. Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis;Brain Pathology;2024-01-11
3. Paediatric parenchymal neurocysticercosis with pleomorphic clinico-radiological presentations: a case series;Egyptian Pediatric Association Gazette;2023-12-08
4. Albendazole – Ivermectin combination decreases inflammation in experimental neurocysticercosis;Experimental Parasitology;2023-08
5. Neurocysticercosis in non-endemic regions: The experience of Qatar;Frontiers in Neurology;2023-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3